Ironwood Pharmaceuticals, Inc. ( IRWD) - Key Metrics

IRWD Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $0.68 $0.31 $0.35 $0.35
2026Q1 $0.65 $0.25 $0.03 $0.03
2025Q4 $0.29 -$0.01 $0.46 $0.46
2025Q3 $0.75 $0.25 $0.29 $0.29
2025Q2 $0.53 $0.15 -$0.09 -$0.09

IRWD Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 3.40
2026Q1 0% 3.51
2025Q4 0% -60.18
2025Q3 0% 1.31
2025Q2 0% 1.20

IRWD Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 8.37% 0%
2026Q1 0.89% 0%
2025Q4 13.64% 0%
2025Q3 22.39% 0%
2025Q2 -12.99% 0%

IRWD

Price: $3.50

52 week price:
1.41
5.78

Earnings Per Share: 0.79 USD

P/E Ratio: 5.47

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 405820

Ebitda: 26.2 million

Market Capitalization: 596.7 million

Links: